Watson’s Generic Version of Lotrel Receives FDA Approval

Watson Pharmaceuticals, Inc. announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application for Amlodipine Besylate/Benazepril 5/20mg, 10/20mg, 2.5/10mg, and 5/10mg capsules, the generic equivalent to Novartis’ Lotrel capsules.
Earth Times